Home » Topics » Regulatory

Regulatory
RSS

Lunesta approved for treatment of insomnia

Dec. 17, 2004

No Comments

Equetro approved for bipolar disorder

Dec. 15, 2004

No Comments

Tumor necrosis factor inhibitor may attenuate postmyocardial infarction ventricular remodeling

Dec. 3, 2004

No Comments

Diovan approved in Sweden to treat high-risk heart attack patients

Dec. 3, 2004

No Comments

Atacand approved in Europe for treatment of chronic heart failure

Nov. 30, 2004

No Comments

Combunox approved for short-term management of acute moderate/severe pain

Nov. 30, 2004

No Comments

Tysabri approved for multiple sclerosis

Nov. 25, 2004

No Comments

Tarceva approved for advanced NSCLC

Nov. 22, 2004

No Comments

Norditropin approved for adults with severe growth hormone deficiency

Nov. 9, 2004

No Comments

New approval for Eloxatin

Nov. 9, 2004

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Regulatory
RSS

Lunesta approved for treatment of insomnia

Equetro approved for bipolar disorder

Tumor necrosis factor inhibitor may attenuate postmyocardial infarction ventricular remodeling

Diovan approved in Sweden to treat high-risk heart attack patients

Atacand approved in Europe for treatment of chronic heart failure

Combunox approved for short-term management of acute moderate/severe pain

Tysabri approved for multiple sclerosis

Tarceva approved for advanced NSCLC

Norditropin approved for adults with severe growth hormone deficiency

New approval for Eloxatin

Today's news in brief

Today's news in brief

Protein design: if you can’t find ’em, make ’em

Gilead ends $785M Yuhan deal for small-molecule MASH drugs

FDA gives early nod to Genentech’s first-line breast cancer drug

Regulatory RSS

Regulatory
RSS